Evidence map›Paper›PMID 31429197›Full record

ReviewJournal of cachexia, sarcopenia and muscle2019

Remarks on the design and analyses of longitudinal studies for cancer patients with anorexia and weight loss.

Jennifer G Le-Rademacher, Elizabeth M Storrick, Aminah Jatoi

Abstract readReview
In one paragraph

Review in Journal of cachexia, sarcopenia and muscle, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jennifer G Le-RademacherDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-2234-7430
Elizabeth M StorrickDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Aminah JatoiDepartment of Oncology, Mayo Clinic, Rochester, MN, USA.

Funding

Repurposing Disulfiram: A Novel Strategy to Help Cancer Patients Regain MuscleR01CA195473 · NCI · MAYO CLINIC ROCHESTER · PI FERNANDEZ-ZAPICO, MARTIN ERNESTO, JATOI, AMINAH · 2015 to 2020
$2.3M
NCI NIH HHS R01 CA195473United States National Institutes of Health R01CA195473
6 · The paper itself

Abstract

Longitudinal data serve an important role in understanding the cancer anorexia weight loss syndrome and in testing interventions to palliative and treat patients who develop this syndrome. The element of time and the interrelatedness of data points define longitudinal data and add to the richness of this type of data. However, longitudinal data can also give rise to non-random, missing data that can lead to flawed conclusions. This paper discusses these issues and suggests practical considerations for design and analysis of longitudinal cancer anorexia weight loss studies.

Indexed as

AnorexiaCachexiaGuideline AdherenceHumansLongitudinal StudiesNeoplasmsPalliative CareResearch DesignWeight LossCancer anorexia studiesDesign considerationsLongitudinal data analysisMissing dataWeight loss studies

Identifiers

PMID31429197
PMCPMC6903440

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.